Climate Change Data

ADL BIONATUR SOLUTIONS, S.A.

Climate Impact & Sustainability Data (2018-12 to 2021-12, 2019-01 to 2019-06)

Reporting Period: 2018-12 to 2021-12

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Sustainability
  • Circular Economy

Environmental Achievements

  • Manufacturing of products using fermentation processes instead of natural resources or chemical synthesis, allowing for cost reduction and more ecological and sustainable production.

Social Achievements

  • Not disclosed

Governance Achievements

  • Not disclosed

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Large multinational companies in human and animal health could internalize a larger part of the production.
  • Possible problems for scaling products or poor execution of scaling.
  • Tariff restrictions on free trade.
  • Products not being effective or not receiving authorizations.
  • Unforeseen changes in regulations that generate additional costs.
  • Environmental risks.
  • Potential contamination problems of fermenters.
  • Competition offering more efficient, safer, or cheaper products.
  • Possible capacity expansions of fermentation that could lead to overcapacity in the sector.
  • Dependence on a few clients although with a large market behind it.
  • Technological changes in manufacturing processes.
Mitigation Strategies
  • Not disclosed

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: GMP (Good Manufacturing Practices) by the FDA and EMA

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed

Reporting Period: 2019-01 to 2019-06

Environmental Metrics

Social Achievements

  • Increased number of employees from 314 to 355, largely due to expansion of fermentation operations.

Climate Goals & Targets

Environmental Challenges

  • Negative after-tax results for the period leading to a drop in net equity.
  • Need for greater operating capital as a consequence of substantial growth in the company’s turnover.
  • Inherent risks of business expansion in China and Southeast Asia, including administrative bureaucracy and difficulties obtaining permits.
Mitigation Strategies
  • Signed a financing agreement for €25,000,000 (with potential for €5,000,000 increase) to increase productive capacity and implement the strategic plan for the next four years.
  • Signed an addendum to a contract with a major client for an additional minimum of €2.5 million to increase production.
  • Renewed a contract with a main client for 2020 with a minimum value of €12 million.
  • Signed a collaboration agreement with a major Japanese pharmaceutical company with an initial value of €13 million and a duration of 5 years.
  • Signed a support and technological services contract for €2,520,000.

Supply Chain Management

Climate-Related Risks & Opportunities